Jiuzhou Pharmaceutical: Zhejiang Jiuzhou Pharmaceutical Co., Ltd.\'s 2021 Annual Equity Distribution Implementation Notice
Jiuzhou Pharmaceutical: Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the 2021 profit distribution plan
Jiuzhou Pharmaceutical: Announcement by Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the completion of the acquisition of 100% of the shares of Taihua Pharmaceutical Chemical (Hangzhou) Co., Ltd.
Jiuzhou Pharmaceutical: An indicative announcement on the controlling shareholder's non-public offering of exchangeable corporate bonds (Phase II) to enter the share exchange period
Jiuzhou Pharmaceutical: Announcement on the completion of the issuance of non-public exchangeable corporate bonds issued by the controlling shareholder in 2019
Jiuzhou Pharmaceutical: Additional announcement on the progress of the acquisition of 100% shares in Suzhou Novartis Pharmaceutical Technology Co., Ltd.
Jiuzhou Pharmaceutical: Progress announcement on the acquisition of 100% of Suzhou Novartis Pharmaceutical Technology Co., Ltd.
Jiuzhou Pharmaceutical: Announcement on the proposed acquisition of 100% of the shares of Suzhou Novartis Pharmaceutical Technology Co., Ltd.
Jiuzhou Pharmaceutical: Announcement on the acquisition of 25% of Fangda Pharmaceutical Technology (Suzhou) Co., Ltd.
Jiuzhou Pharmaceutical: Announcement on Sale of Shares in Holding Subsidiaries